Gender impact on prognosis of acute coronary syndrome patients treated with drug-eluting stents

American Journal of Cardiology

Volumn 110, Issue 5, 2012, Pages 636-642

  Fath Ordoubadi, Farzin ^a   Barac, Yaron ^b   Abergel, Eitan ^b   Danzi, Gian Battista ^c   Kerner, Arthur ^b   Nikolsky, Eugenia ^b   Halabi, Majdi ^b   Mamas, Mamas ^a   El Omar, Magdi ^a   Fraser, Doug ^a   Roguin, Ariel ^b  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^b RAMBAM MEDICAL CENTER   (Israel)

^c FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; NOBORI; UMIROLIMUS; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; ADULT; AGE; ANALGESIA; ANGINA PECTORIS; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY RECANALIZATION; DIABETES MELLITUS; DRUG ELUTING STENT; FEMALE; HEART DEATH; HEART INFARCTION; HUMAN; HYPERTENSION; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE; STENT THROMBOSIS; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANGIOPLASTY, BALLOON, CORONARY; CAUSE OF DEATH; CORONARY ANGIOGRAPHY; DRUG-ELUTING STENTS; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SINGLE-BLIND METHOD; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84864915091     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.04.039     Document Type: Article

References (25)

1. H. Jneid, G.C. Fonarow, C.P. Cannon, A.F. Hernandez, I.F. Palacios, A.O. Maree, Q. Wells, B. Bozkurt, K.A. Labresh, L. Liang, Y. Hong, L.K. Newby, G. Fletcher, E. Peterson, L. Wexler Get With the Guidelines Steering Committee and Investigators Sex differences in medical care and early death after acute myocardial infarction Circulation 118 2008 2803 2810
2. J.D. Abbott, H.A. Vlachos, F. Selzer, B.L. Sharaf, E. Holper, R. Glaser, A.K. Jacobs, D.O. Williams National Heart, Lung, and Blood Institute Dynamic Registry Gender-based outcomes in percutaneous coronary intervention with drug-eluting stents (from the National Heart, Lung, and Blood Institute Dynamic Registry) > Am J Cardiol 99 2007 626 631
3. A.K. Jacobs Coronary intervention in 2009: are women no different than men? Circ Cardiovasc Interv 2 2009 69 78
4. C. Milcent, B. Dormont, I. Durand-Zaleski, P.G. Steg Gender differences in hospital mortality and use of percutaneous coronary intervention in acute myocardial infarction: microsimulation analysis of the 1999 nationwide French hospitals database Circulation 115 2007 833 839
5. M. Singh, C.S. Rihal, B.J. Gersh, V.L. Roger, M.R. Bell, R.J. Lennon, A. Lerman, D.R. Holmes Jr Mortality differences between men and women after percutaneous coronary interventions A 25-year, single-center experience J Am Coll Cardiol 51 2008 2313 2320
6. A.K. Jacobs The efficacy of drug-eluting stents in women A window of opportunity JACC Cardiovasc Interv 2 2009 611 613
7. A.J. Lansky, J.S. Hochman, P.A. Ward, G.S. Mintz, R. Fabunmi, P.B. Berger, G. New, C.L. Grines, C.G. Pietras, M.J. Kern, M. Ferrell, M.B. Leon, R. Mehran, C. White, J.H. Mieres, J.W. Moses, G.W. Stone, A.K. Jacobs American College of Cardiology Foundation Percutaneous coronary intervention and adjunctive pharmacotherapy in women: a statement for healthcare professionals from the American Heart Association Circulation 111 2005 940 953
8. A.K. Jacobs, J.M. Johnston, A. Haviland, M.M. Brooks, S.F. Kelsey, D.R. Holmes Jr, D.P. Faxon, D.O. Williams, K.M. Detre Improved outcomes for women undergoing contemporary percutaneous coronary intervention: a report from the National Heart, Lung, and Blood Institute Dynamic registry J Am Coll Cardiol 39 2002 1608 1614
9. Y. Onuma, N. Kukreja, J. Daemen, H.M. Garcia-Garcia, N. Gonzalo, J.M. Cheng, P.H. van Twisk, R. van Domburg, P.W. Serruys Interventional Cardiologists of Thoraxcenter Impact of sex on 3-year outcome after percutaneous coronary intervention using bare-metal and drug-eluting stents in previously untreated coronary artery disease: insights from the RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) registries JACC Cardiovasc Interv 2 2009 603 610
10. J.L. Mega, J.S. Hochman, B.M. Scirica, S.A. Murphy, S. Sloan, C.H. McCabe, P. Merlini, D.A. Morrow Clinical features and outcomes of women with unstable ischemic heart disease: observations from Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-elevation acute coronary syndromes-Thrombolysis In Myocardial Infarction 36 (MERLIN-TIMI 36) Circulation 121 2010 1809 1810
11. R. Jibran, J.A. Khan, A. Hoye Gender disparity in patients undergoing percutaneous coronary intervention for acute coronary syndromes - does it still exist in contemporary practice? Ann Acad Med Singapore 39 2010 173 178
12. N. Akhter, S. Milford-Beland, M.T. Roe, R.N. Piana, J. Kao, A. Shroff Gender differences among patients with acute coronary syndromes undergoing percutaneous coronary intervention in the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR) Am Heart J 157 2009 141 148
13. R. Glaser, F. Selzer, A.K. Jacobs, W.K. Laskey, S.F. Kelsey, E.M. Holper, H.A. Cohen, J.D. Abbott, R.L. Wilensky Effect of gender on prognosis following percutaneous coronary intervention for stable angina pectoris and acute coronary syndromes Am J Cardiol 98 2006 1446 1450
14. B. Chevalier, P.W. Serruys, S. Silber, E. Garcia, H. Suryapranata, K. Hauptmann, W. Wijns, G. Schuler, F. Fath-Ordoubadi, S. Worthley, L. Thuesen, I. Meredith, M. Bressers, H. Nagai, D. Paunovic Randomised comparison of Nobori, biolimus A9-eluting coronary stent with a Taxus(R), paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the Nobori 1 trial EuroIntervention 2 2007 426 434
15. B. Chevalier, S. Silber, S.J. Park, E. Garcia, G. Schuler, H. Suryapranata, J. Koolen, K.E. Hauptmann, W. Wijns, M.C. Morice, D. Carrie, G.A. van Es, H. Nagai, D. Detiege, D. Paunovic, P.W. Serruys NOBORI 1 Clinical Investigators Randomized comparison of the Nobori Biolimus A9-eluting coronary stent with the Taxus Liberté paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the NOBORI 1 trial - phase 2 Circ Cardiovasc Interv 2 2009 188 195
16. M. Ostojic, D. Sagic, B. Beleslin, R. Jung, Z. Perisic, N. Jagic, M. Nedeljkovic, L. Mangovski, B. Milosavljevic, S. Stojkovic, D. Orlic, Z. Antonic, V. Miloradovic, D. Topic, D. Paunovic First clinical comparison of Nobori-Biolimus A9 eluting stents with Cypher-Sirolimus eluting stents: Nobori Core nine months angiographic and one year clinical outcomes EuroIntervention 3 2008 574 579
17. J. Mehilli, A. Kastrati, J. Dirschinger, H. Bollwein, F.J. Neumann, A. Schömig Differences in prognostic factors and outcomes between women and men undergoing coronary artery stenting JAMA 284 2000 1799 1805
18. F. Alfonso, R. Hernández, C. Bañuelos, A. Fernández-Ortíz, J. Escaned, M. Sabaté, M.J. Pérez-Vizcayno, C. Fernández, C. Macaya Initial results and long-term clinical and angiographic outcome of coronary stenting in women Am J Cardiol 86 2000 1380 1383
19. T. Robertson, E.D. Kennard, S. Mehta, J.J. Popma, J.P. Carrozza Jr, S.B. King III, D.R. Holmes, M.J. Cowley, C.A. Hornung, K.M. Kent, G.S. Roubin, F. Litvack, J.W. Moses, R. Safian, P. Desvigne-Nickens, K.M. Detre Influence of gender on in-hospital clinical and angiographic outcomes and on one-year follow-up in the New Approaches to Coronary Intervention (NACI) registry Am J Cardiol 80 suppl 1997 26K 39K
20. C.T. Watanabe, C. Maynard, J.L. Ritchie Comparison of short-term outcomes following coronary artery stenting in men versus women Am J Cardiol 88 2001 848 852
21. C.A. Thompson, A.V. Kaplan, B.J. Friedman, J.E. Jayne, B.R. Gerling, N.W. Niles, B.D. Hettleman, J.F. Robb Gender-based differences of percutaneous coronary intervention in the drug-eluting stent era Catheter Cardiovasc Interv 67 2006 25 31
22. E. Solinas, E. Nikolsky, A.J. Lansky, A.J. Kirtane, M.C. Morice, J.J. Popma, J. Schofer, E. Schampaert, T. Pucelikova, J. Aoki, M. Fahy, G.D. Dangas, J.W. Moses, D.E. Cutlip, M.B. Leon, R. Mehran Gender-specific outcomes after sirolimus-eluting stent implantation J Am Coll Cardiol 50 2007 2111 2116
23. A.J. Lansky, R.A. Costa, M. Mooney, M.G. Midei, H.K. Lui, W. Strickland, R. Mehran, M.B. Leon, M.E. Russell, S.G. Ellis, G.W. Stone TAXUS-IV Investigators Gender-based outcomes after paclitaxel-eluting stent implantation in patients with coronary artery disease J Am Coll Cardiol 45 2005 1180 1185
24. S.R. Mehta, J.F. Tanguay, J.W. Eikelboom, S.S. Jolly, C.D. Joyner, C.B. Granger, D.P. Faxon, H.J. Rupprecht, A. Budaj, A. Avezum, P. Widimsky, P.G. Steg, J.P. Bassand, G. Montalescot, C. Macaya, G. Di Pasquale, K. Niemela, A.E. Ajani, H.D. White, S. Chrolavicius, P. Gao, K.A. Fox, S. Yusuf CURRENT-OASIS 7 Trial Investigators Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial Lancet 376 2010 1233 1243
25. V.G. Ng, A.J. Lansky, J.B. Hermiller, N. Farhat, R.J. Applegate, M. Yaqub, P. Sood, X. Su, C.A. Simonton, K. Sudhir, G.W. Stone Three-year results of safety and efficacy of the everolimus-eluting coronary stent in women (from the SPIRIT III randomized clinical trial) Am J Cardiol 107 2011 841 848